Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Inventory (2020 - 2026)

IceCure Medical has reported Inventory over the past 7 years, most recently at $2.6 million for Q1 2026.

  • For Q1 2026, Inventory changed N/A year-over-year to $2.6 million; the TTM value through Mar 2026 reached $2.6 million, changed N/A, while the annual FY2025 figure was $2.6 million, 32.04% up from the prior year.
  • Inventory was $2.6 million for Q1 2026 at IceCure Medical, up from $2.6 million in the prior quarter.
  • Across five years, Inventory topped out at $2.9 million in Q4 2022 and bottomed at $2.0 million in Q4 2024.
  • The 5-year median for Inventory is $2.6 million (2025), against an average of $2.5 million.
  • Year-over-year, Inventory surged 46.14% in 2022 and then decreased 20.37% in 2023.
  • Over 5 years, Inventory stood at $2.9 million in 2022, then decreased by 20.37% to $2.3 million in 2023, then decreased by 12.62% to $2.0 million in 2024, then skyrocketed by 32.04% to $2.6 million in 2025, then increased by 0.8% to $2.6 million in 2026.
  • The last three reported values for Inventory were $2.6 million (Q1 2026), $2.6 million (Q4 2025), and $2.0 million (Q4 2024) per Business Quant data.